Author:
Schneider Yanni,Wihan Jeanette,Turan Soeren,Winkler Jürgen
Publisher
Springer International Publishing
Reference110 articles.
1. Baba M, Nakajo S, Tu PH, Tomita T, Nakaya K, Lee VM, Trojanowski JQ, Iwatsubo T (1998) Aggregation of alpha-synuclein in Lewy bodies of sporadic Parkinson's disease and dementia with Lewy bodies. Am J Pathol 152:879–884. https://www.ncbi.nlm.nih.gov/pubmed/9546347
2. Backlund EO, Granberg PO, Hamberger B, Knutsson E, Martensson A, Sedvall G, Seiger A, Olson L (1985) Transplantation of adrenal medullary tissue to striatum in parkinsonism. First clinical trials J Neurosurg 62:169–173. https://www.ncbi.nlm.nih.gov/pubmed/257855810.3171/jns.1985.62.2.0169
3. Barker RA, Drouin-Ouellet J, Parmar M (2015) Cell-based therapies for Parkinson disease-past insights and future potential. Nat Rev Neurol 11:492–503. https://www.ncbi.nlm.nih.gov/pubmed/2624003610.1038/nrneurol.2015.123
4. Barker RA, Parmar M, Studer L, Takahashi J (2017) Human trials of stem cell-derived dopamine neurons for Parkinson’s disease: Dawn of a new era. Cell Stem Cell 21:569–573. https://www.ncbi.nlm.nih.gov/pubmed/2910001010.1016/j.stem.2017.09.014
5. Barrangou R, Fremaux C, Deveau H, Richards M, Boyaval P, Moineau S, Romero DA, Horvath P (2007) CRISPR provides acquired resistance against viruses in prokaryotes. Science 315:1709–1712. https://www.ncbi.nlm.nih.gov/pubmed/1737980810.1126/science.1138140